When Canadian drug maker Valeant paid more than $150 million for the rights to Johnson & Johnson’s talcum powder in 2012, it also apparently bought the rights to defend dozens of talcum powder ovarian cancer lawsuits. Last month, Valeant CEO Joseph Papa commented to investors and analysts, “it is our belief that J&J has obligations to pay for our legal defense and to indemnify Valeant.”
Talcum Powder Ovarian Cancer Lawsuits
Valeant currently faces 33 talcum powder ovarian cancer lawsuits, as of its last 10-k filing, and the number is expected to grow. Johnson & Johnson faces thousands of such cases, reporting 3,100 on its last 10-k filing. The company has so far been on the short end of four verdicts for $110 million, $72 million, $55 million, and $70 million, but still insists that its talc products are safe and it plans to appeal the decisions.
Besides the talcum powder lawsuits, other looming issues for Valeant include an insider trading lawsuit, more product liability and class action lawsuits, a Security and Exchange Commission (SEC) investigation, a Southern District investigation involving fraud and kickbacks, and an Internal Revenue Service (IRS) review.
Does Talcum Powder Really Cause Ovarian Cancer?
Talcum powder is made from talc, a mineral made up mainly of the elements magnesium, silicon, and oxygen. Talcum powder absorbs moisture well and helps cut down on friction, making it useful for keeping skin dry and helping to prevent rashes.
Most concerns about a possible link between talcum powder and ovarian cancer focus on whether people who have long-term exposure to natural talc fibers at work are at higher risk of lung cancer from breathing them in, and whether women who apply talcum powder regularly in the genital area have an increased risk of ovarian cancer.
If you have friends and family who are regular talcum powder users, please share this blog information with them, and continue to follow TruLaw for further talcum powder ovarian cancer lawsuit updates.